Carbinoxamine

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

H1 antagonist.

IndicationThis section has been translated automatically.

Allergic reactions, eczema, pruritus.

Dosage and method of useThis section has been translated automatically.

  • 2 times 12 mg/day p.o.
  • Children 6-12 years: 3 times 5 ml/day p.o.
  • Children 3-6 years: 3 times 2,5-5 ml/day p.o.
  • Children 1-3 years: 3 times 2.5 ml/day p.o.

Undesirable effectsThis section has been translated automatically.

Sedation, central nervous disorders, dry mouth, gastrointestinal disorders, scalp itching, photosensitivity, paragroup allergy (polistine ped).

InteractionsThis section has been translated automatically.

Strengthening the effect of centrally attenuating drugs and alcohol.

ContraindicationThis section has been translated automatically.

Pregnancy, lactation, paragroup allergy (polist ped).

PreparationsThis section has been translated automatically.

Allergefon (only available through the international pharmacy).

Note(s)This section has been translated automatically.

Remember! Patients must be informed of the significant reduction in their ability to react before therapy begins!

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer